Oxygen-mediated parenchymal and vascular lung injury

Acta Pharmacologica Sinica

Volumn 23, Issue SUPPL., 2002, Pages 22-28

  Luo, Xiao Ping ^a,b   Jankov, Robert P ^b   Ning, Qin ^a   Liao, Ling Jie ^a   Tanswell, A Keith ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antioxidants; Bronchopulmonary dysplasia; Endothelin; Hyperoxia; Pulmonary hypertention; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; ENDOTHELIN 1; HYDROGEN PEROXIDE; ISOPROSTANE; OXYGEN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL INJURY; CELL DEATH; CELL GROWTH; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; HOST RESISTANCE; HYPEROXIA; INTENSIVE CARE; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG INJURY; LUNG PARENCHYMA; MORBIDITY; MORTALITY; NECROSIS; NEWBORN CARE; NONHUMAN; OXIDATION; OXYGEN TOXICITY; PREMATURITY; PULMONARY HYPERTENSION; RAT; TREATMENT PLANNING;

EID: 0036817698     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Northway Jr WH, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy for hyaline membrane disease. N Engl J Med 1967; 276: 357-68.
2. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527-32.
3. O'Brodovich HM, Mellins RB. Bronchopulmonary dysplasia: Unresolved neonatal acute lung injury. Am Rev Respir Dis 1985; 132: 694-709.
4. Bancalari E, Gonzalez A. Clinical course and lung function abnormalities during development of neonatal chronic lung disease. In: Bland RD, Coalson JJ, editors. Chronic lung disease in early infancy. New York: Marcel Dekker; 2000. p 41-64.
5. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-9.
6. Coalson JJ. Pathology of chronic lung disease of early infancy. In: Bland RD, Coalson JJ, editors. Chronic Lung Disease in Early Infancy. New York: Marcel Dekker; 2000. p 85-124.
7. Goodman G, Perkin RM, Anas NG, Sperling DR, Hicks DA, Rowen M. Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1988; 112: 67-72.
8. Saugstad OD. Chronic lung disease: The role of oxidative stress. Biol Neonate 1998; 74 Suppl 1: 21-8.
9. Adamson IYR. Alveolar injury and repair. In: Schraufngel, DE, et al, editors. Electron Microscopy of the Lung. New York: Marcel Dekker; 1994. p 149-76.
10. Jassal D, Han RNN, Caniggia I, Post M, Tanswell AK. Growth of distal fetal rat lung epithelial cells in a defined serum-free medium. In Vitro Cell Dev Biol 1991; 27: 625-32.
11. 2-mediated injury of preterm pneumocytes in vitro. Arch Biochem Biophys 1994; 313: 131-6.
12. Tanswell AK, Olson DA, Freeman BA. Liposome-mediated augmentation of antioxidant defenses in fetal rat pneumocytes. Am J Physiol 1990; 258: L165-72.
13. 2 toxicity in cultured fetal rat distal lung epithelial cells. Free Radic Biol Med 1999; 26: 1357-68.
14. Saugstad OD. Brochopulmonary dysplasia and oxidative stress: Are we closer to an understanding of pathogenesis of BPD? Acta Paediatr 1997; 86: 1277-82.
15. Luo X, Sedlackova L, Belcastro R, Cabacungan J, Lye SJ, Tanswell AK. Effect of the 21-aminosteroid U74389G on oxygen-induced free radical production, lipid peroxidation, and inhibition of lung growth in neonatal rats. Pediatr Res 1999; 46: 215-23.
16. Jankov RP, Negus A, Tanswell AK. Antioxidants as therapy in the newborn: Some words of caution. Pediatr Res 2001; 50: 681-7.
17. Coalson JJ, Winter V, deLemos RA. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995; 152: 640-6.
18. Han RN, Buch S, Tseu I, Young J, Christie NA, Frndova H, et al. Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60 % oxygen. Pediatr Res 1996; 39: 921-9.
19. Veness-Meehan KA, Moats-Staats BM, Price WA, Stiles AD. Re-emergence of a fetal pattern of insulin-like growth factor expression during hyperoxic rat lung injury. Am J Respir Cell Mol Biol 1997; 16: 538-48.
20. Warner BB, Stuart LA, Papes RA, Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998; 275: L110-7.
21. 2. Pediatr Res 2000; 48: 423-33.
22. Koppel R, Han RN, Cox D, Tanswell AK, Rabinovitch M. Alpha 1-antitrypsin protects neonatal rats from pulmonary vascular and parenchymal effects of oxygen toxicity. Pediatr Res 1994; 36: 763-70.
23. Subhedar NV, Hamdan AH, Ryan SW, Shaw NJ. Pulmonary artery pressure: Early predictor of chronic lung disease in preterm infants. Arch Dis Child 1998; 78: F20-4.
24. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl Med 1993; 328: 1732-9.
25. Soma S, Takahashi H, Muramatsu M, Oka M, Fukuchi Y. Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. Am J Respir Cell Mol Biol 1999; 20: 620-30.
26. 2-mediated pulmonary hypertension in neonatal rats: A role for products of lipid peroxidation. Pediatr Res 2000; 48: 289-98.
27. 2 receptors mediate pulmonary hypertension in 60 % oxygen-exposed newborn rats by a cyclooxygenase-independent pathway. Am J Respir Crit Care Med 2002; 166: 208-14.
28. Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Glover DM, et al. Endothelin, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990; 172: 1741-8.
29. Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 1999; 158: S18-22.
30. Pendino KJ, Meidhof TM, Heck DE, Laskin JD, Laskin DL. Inhibition of macrophages with gadolinium chloride abrogates ozone-induced pulmonary injury and inflammatory mediator production. Am J Respir Cell Mol Biol 1995; 13: 125-32.
31. Liu M, Xu J, Tanswell AK, Post M. Inhibition of mechanical strain-induced fetal rat lung cell proliferation by gadolinium, a stretch-activated channel blocker. J Cell Physiol 1994; 161: 501-7.
32. 2-induced pulmonary hypertension in the neonatal rat. Pediatr Res 2001; 50: 172-83.
33. Deng H, Mason SN, Auten RL. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 2000; 162: 2316-23.